704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates.

Colombani T, Haudebourg T, Pitard B

Open source

DOI
10.1016/j.omtn.2023.04.029
Published
2023 Jun 13
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2023.04.029,
  title = {704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates.},
  author = {Colombani T and Haudebourg T and Pitard B},
  year = {2023},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2023.04.029},
  url = {https://doi.org/10.1016/j.omtn.2023.04.029}
}

RIS

TY  - JOUR
TI  - 704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates.
AU  - Colombani T
AU  - Haudebourg T
AU  - Pitard B
PY  - 2023
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2023.04.029
UR  - https://doi.org/10.1016/j.omtn.2023.04.029
ER  - 

APA

T, C., T, H., & B, P. (2023). 704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2023.04.029

Source records